Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01416233 · ClinicalTrials.gov registry record · NA
Autologous Fat Augmentation of Orbital Volume Using a Closed Cannula Technique
A NA study of Orbital Fat Atrophy, sponsored by Fox, Donald Munro, M.D., P.C..
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
- 1
- Study location
NCT01416233 is a NA study of Orbital Fat Atrophy that has completed, run by Fox, Donald Munro, M.D., P.C.. The registered enrollment target is 6 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01416233, a NA study of Orbital Fat Atrophy, has completed, sponsored by Fox, Donald Munro, M.D., P.C..
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
After enucleation or evisceration with placement of a dermis fat graft or integrated orbital implant as a primary procedure, there can be secondary loss of orbital fat volume causing regression of periocular tissue and malpositioning of the cosmetic shell. Current techniques for correction require open surgery to place a sheet/block of biocompatible material or a macroaggregate of fat into the orbit to augment orbital volume for permanent correction. Alternatively, hyaluronic acid-base fillers (Restylane, Radiesse) have been injected, but these have proved to be temporary. The current study seeks to show that a permanent augmentation of orbital volume can be achieved using a closed cannula injection of autologous fat.
Conditions Studied
Interventions
- PROCEDURE autologous fat grafting to the orbit
Study Locations (1)
New York
- New York Eye and Ear Infirmary - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2010-09 |
| Est. Completion | 2017-12-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01416233
The ClinicalTrials.gov registry entry for NCT01416233 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fox, Donald Munro, M.D., P.C., which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Orbital Fat Atrophy appearing as the primary indexed condition, and to 1 intervention - of which autologous fat grafting to the orbit is the first listed.
NCT01416233 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT01416233 about?
NCT01416233 is a clinical study titled "Autologous Fat Augmentation of Orbital Volume Using a Closed Cannula Technique". After enucleation or evisceration with placement of a dermis fat graft or integrated orbital implant as a primary procedure, there can be secondary loss of orbital fat volume causing regression of periocular tissue and malpositioning of the cosmetic shell. Current techniques for correction require o...
What is the current status of trial NCT01416233?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2010-09. Estimated completion is 2017-12-10.
What conditions does trial NCT01416233 study?
This clinical trial studies the following conditions: Orbital Fat Atrophy.
What interventions are being tested in trial NCT01416233?
The interventions under investigation include: autologous fat grafting to the orbit (PROCEDURE).
Who is sponsoring clinical trial NCT01416233?
This trial is sponsored by Fox, Donald Munro, M.D., P.C., which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01416233 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.